The anaplastic lymphoma kinase (ALK) is abnormally expressed and hyperactivated in a number of tumors and represents an ideal therapeutic target. Despite excellent clinical responses to ALK inhibition, drug resistance still represents an issue and novel compounds that overcome drug-resistant mutants are needed. We designed, synthesized, and evaluated a large series of azacarbazole inhibitors. Several lead compounds endowed with submicromolar potency were identified. Compound 149 showed selective inhibition of native and mutant drug-refractory ALK kinase in vitro as well as in a Ba/F3 model and in human ALK+ lymphoma cells. The three-dimensional (3D) structure of a 149:ALK-KD cocrystal is reported, showing extensive interaction through the hinge region and the catalytic lysine 1150.

Mologni, L., Tardy, S., Zambon, A., Orsato, A., Bisson, W., Ceccon, M., et al. (2022). Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase. ACS OMEGA, 7(20), 17083-17097 [10.1021/acsomega.2c00507].

Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase

Mologni, Luca
Primo
;
Orsato, Alexandre;Ceccon, Monica;Viltadi, Michela;Vece, Vito;Gambacorti-Passerini, Carlo
Ultimo
2022

Abstract

The anaplastic lymphoma kinase (ALK) is abnormally expressed and hyperactivated in a number of tumors and represents an ideal therapeutic target. Despite excellent clinical responses to ALK inhibition, drug resistance still represents an issue and novel compounds that overcome drug-resistant mutants are needed. We designed, synthesized, and evaluated a large series of azacarbazole inhibitors. Several lead compounds endowed with submicromolar potency were identified. Compound 149 showed selective inhibition of native and mutant drug-refractory ALK kinase in vitro as well as in a Ba/F3 model and in human ALK+ lymphoma cells. The three-dimensional (3D) structure of a 149:ALK-KD cocrystal is reported, showing extensive interaction through the hinge region and the catalytic lysine 1150.
Articolo in rivista - Articolo scientifico
Assays, Inhibition, Inhibitors, Substituents
English
14-mag-2022
2022
7
20
17083
17097
open
Mologni, L., Tardy, S., Zambon, A., Orsato, A., Bisson, W., Ceccon, M., et al. (2022). Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase. ACS OMEGA, 7(20), 17083-17097 [10.1021/acsomega.2c00507].
File in questo prodotto:
File Dimensione Formato  
10281-407116_VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 4.43 MB
Formato Adobe PDF
4.43 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/407116
Citazioni
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 8
Social impact